Cargando…

Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report

Immune checkpoint inhibitors (ICIs) targeting programmed death-1 (PD-1) pathway have significantly improved outcomes for patients with a variety of malignancies, including non-small cell lung cancer (NSCLC). In contrast, the incidence of immune-related cutaneous adverse events such as vitiligo have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Sook Jung, Oh, In-Jae, Park, Cheol Kyu, Kim, Young-Chul, Kim, Hyeon Bin, Kim, Hee-Kyung, Hong, A. Ram, Kim, In-Young, Ahn, Sung-Ja, Na, Kook-Joo, Choi, Yoo-Duk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481606/ https://www.ncbi.nlm.nih.gov/pubmed/32953529 http://dx.doi.org/10.21037/tlcr-20-386

Ejemplares similares

Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream
por: Kim, Na Hee, et al.
Publicado: (2018)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015)

Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
por: Agarwal, Priti, et al.
Publicado: (2014)

Psychosocial and quality-of-life factors associated with depigmentation therapy for vitiligo
por: Cadmus, Simi D., et al.
Publicado: (2023)

VITILIGO: A REVIEW OF SOME FACTS LESSER KNOWN ABOUT DEPIGMENTATION
por: Nordlund, James J
Publicado: (2011)

Depigmentation Therapy with Q-Switched Nd: YAG Laser in Universal Vitiligo
por: Majid, Imran, et al.
Publicado: (2013)

Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata
por: Alatabani, Maram, et al.
Publicado: (2021)

The First Human Clinical Trial on the Skin Depigmentation Efficacy of Glycinamide Hydrochloride
por: Boo, Yong Chool, et al.
Publicado: (2020)

A Case of Vitiligo Associated with Paraffin Injection
por: Kim, Seo Wan, et al.
Publicado: (2014)

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine
por: Bakr, Farrah, et al.
Publicado: (2022)

Tislelizumab Induced Vitiligo-Like Depigmentation in a Chinese Patient with Oesophageal Squamous Cell Carcinoma
por: Li, Ping, et al.
Publicado: (2022)

A Multicenter Collaborative Study by the Korean Society of Vitiligo about Patients' Occupations and the Provoking Factors of Vitiligo
por: Jeon, In Kyung, et al.
Publicado: (2014)

Prevalence of Vitiligo and Associated Comorbidities in Korea
por: Lee, Hemin, et al.
Publicado: (2015)

Bilateral acute depigmentation of iris
por: Yangzes, Sonam, et al.
Publicado: (2019)

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo
por: Kim, Young Jee, et al.
Publicado: (2015)

PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin
por: Miao, Xiao, et al.
Publicado: (2018)

Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding
por: Yin, Emily S., et al.
Publicado: (2017)

Equine vitiligo-like depigmentation in grey horses is related to genes involved in immune response and tumor metastasis
por: Druml, Thomas, et al.
Publicado: (2021)

Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer
por: Yoon, Joon‐Young, et al.
Publicado: (2019)

Pulmonary epithelioid hemangioendothelioma misdiagnosed as a benign nodule
por: Kim, Minah, et al.
Publicado: (2015)

Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study
por: Park, Cheol Kyu, et al.
Publicado: (2016)

A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
por: Park, Cheol-Kyu, et al.
Publicado: (2021)

Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery
por: Kho, Bo Gun, et al.
Publicado: (2020)

Depigmentation Effect of Kadsuralignan F on Melan-A Murine Melanocytes and Human Skin Equivalents
por: Goh, Myeong-Jin, et al.
Publicado: (2013)

Melanoma Inhibitory Activity (MIA) Is Able to Induce Vitiligo-Like Depigmentation in an in vivo Mouse Model by Direct Injection in the Tail
por: Bordignon, Matteo, et al.
Publicado: (2020)

Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study
por: Hermann, Nicola, et al.
Publicado: (2022)

A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board
por: Kim, Min-Seok, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
por: Park, Seongho, et al.
Publicado: (2019)

A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8(+) T cell accumulation in the skin
por: Harris, John E., et al.
Publicado: (2012)

Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Gold Ring Induced Depigmentation
por: Nayak, Sudhir UK, et al.
Publicado: (2013)

Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor
por: Kim, Woo-Jin, et al.
Publicado: (2015)

Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?
por: Serra, Maíra Chiarelli, et al.
Publicado: (2014)

Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer
por: Yoon, Seong-Hoon, et al.
Publicado: (2015)

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response
por: Park, Ha Young, et al.
Publicado: (2016)

Physical activity can reduce the prevalence of gallstone disease among males: An observational study
por: Kwon, Oh-Sung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_99utnf1mrqq10veo6aiomdku12